Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
9
×
deals
9
×
national blog main
vc
9
×
startups
life sciences
boston
national top stories
san francisco blog main
biotech
new york blog main
san francisco top stories
venture capital
new york top stories
san diego blog main
gene therapy
san diego top stories
seattle blog main
.406 ventures
crispr
gene editing
healthcare
hemophilia
illumina
indiana blog main
ipo
medicare
patients
raleigh-durham blog main
rtw investments
san francisco
software
83north venture capital
acetylon pharmaceuticals
acuity link
adeno-associated virus
administration
alexandria venture investments
altitude life science ventures
What
startup
gene
healthcare
medical
medicines
big
bio
biotech
boston
developing
diseases
goes
make
million
new
patients
therapy
transportation
acquisition
advance
aiming
aims
amazon’s
ambys
announced
approach
assistant
based
bay
becker
beta
bigger
billions
bionics
blood
botkeeper
called
cash
ceo
circulation
Language
unset
Current search:
vc
×
deals
×
" boston top stories "
×
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
5 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
Boston Tech Watch: Gradifi, Numerated, Jibo, Corvus, Botkeeper
@xconomy.com
5 years ago
Circulation CEO Talks Sale to LogistiCare & Amazon’s Healthcare Play
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@xconomy.com
5 years ago
Iora Health Goes Big With $100M to Advance Collaborative Care Model